CMO Formex and CRO BioDuro merge operations

San Diego-based contract manufacturer Formex has merged with China-based BioDuro. The merged groups will operate under the BioDuro name out of San Diego. Terms of the deal were not disclosed. BioDuro said in a statement that the combined group will have access to BioDuro's 100,000-square-foot facility in Beijing, where it focuses on biosimilars and other products, and a 44,000-square-foot Formex facility in San Diego. Release

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.